Background: Certain complement defects are associated with increased propensity to 2
RESULTS

2
Concentration of anti-meningococcal antibodies. The concentrations of specific 3 antibodies to group B meningococci in serum from each of the donors were quantified to 4 interpret our results in relation to their antibody levels. In the C5-deficient serum, the 5 concentration of antibodies was 34 AU/ml; similar to levels found in vaccinees after 6 adequate immunization (results not shown). In the C2-deficient serum and in the two 7 control sera, the antibody concentrations were 3-6 AU/ml; i.e. low levels typically found 8 in non-immunized persons. 9
10
Bacterial survival and proliferation in whole blood. First we examined the survival 11 and proliferation of meningococci in freshly drawn whole blood from each of the donors 12 with and without reconstitution of the lacking factors. In the C2-deficient whole blood the 13 number of meningococci increased throughout incubation. The final increase in CFUs 14 was about 2 log 10, while the final increase in DNA copies was 4-5 log 10 ( Fig. 1, upper  15 panels). In the reconstituted C2-deficient blood and in blood from the C2-sufficient 16 control individual, the number of CFUs initially decreased about 2 log 10, and after 2 hours 17 it started to increase, ending up with a similar final number of CFUs as was seen in the 18 C2-deficient blood. The final number of DNA copies in the C2-reconstituted blood did 19 not differ from the C2-deficient blood. 20
21
In the C5-deficient whole blood, the number of meningococci increased throughout 22 incubation. The final increase in CFUs was about 2 log 10 while the final increase in DNA 23 12 copies was 4-5 log 10 ( Fig. 1, lower panels) . In the C5-reconstituted blood the number of 1 CFUs decreased 5 log 10 within 2 hours, implying that all live bacteria were killed. 2 Correspondingly, no increase in the number of DNA copies was seen in the C5-3 reconstituted blood. In blood from the C5-sufficient but MBL-deficient control individual 4 the number of CFUs initially decreased about 2 log 10 , but after 2 hours started to increase, 5 ending up with a similar final number of CFUs as was seen in the C5-deficient blood. 6
Thus, blood from the MBL-deficient control individual behaved similarly to the 7 complement-sufficient control individual in the CFU assay. The control individuals were 8 not examined for meningococcal DNA. 9
10
Opsonophagocytic activity. The influence of C2, MBL, C5 and specific antibodies on 11 opsonophagocytosis was examined with sera from each of the donors. Two-fold titrations 12 of sera from the four individuals were done, and meningococci were added to the 13 dilutions. This was followed by incubation with PMNs and measurement of OPA (Fig. 2,  14 panel A1). PMNs incubated with C2-deficient serum had no detectable OPA. 15 Reconstitution with C2 restored OPA to the level of the C2 control. PMNs incubated with 16 C5-deficient serum revealed high OPA. The activity was at the same level after 17 reconstitution with C5 and MBL. OPA with post-vaccination serum as a positive control 18 serum (TKH) was similar to the activity seen with serum from the C5-deficient patient. 19
With serum from the MBL-deficient C5 control individual the OPA was lower; and 20 similar to the reconstituted C2-deficient serum. OPA was unchanged after reconstitution 21 of the MBL-deficient control serum with MBL. 22 1 meningococci followed by the addition of IgG-depleted homologous serum as the 2 complement source to provide equal concentration of complement factors in all titrations 3 from each donor (Fig. 2, panel A2) . The results proved similar to the previous experiment 4 where native deficient and control sera were titrated against meningococci, showing 5 absence of OPA only with the C2-deficient serum. 6 7 Next, heat-inactivated post-vaccination serum (TKH) was two-fold titrated against 8 meningococci to provide equally high degree of antibody coating before addition of IgG-9 depleted deficient-and control sera as the complement sources (Fig. 2, panel A3 ). The 10 OPA titer was similar when C2-deficient serum was provided as the complement source 11 as it was in the absence of complement (HBSS), which was, however, somewhat higher 12 than the low OPA titer seen with C2-deficient serum in the presence of a low antibody 13 level. After reconstitution with C2 the titer increased to similar high levels as when the 14 other test sera were used as the complement sources. observed after C5 reconstitution of the C5-deficient serum, whereas MBL-reconstitution 10 had no effect on SBA. 11
12
Heat-inactivated sera from the four individuals were then titrated against meningococci, 13
followed by the addition of serum without SBA antibodies against meningococci from a 14 complement sufficient donor as the complement source. SBA was seen only with serum 15 from the C5-deficient patient (Fig. 3, complement. This probably occurred through the involvement of Fc receptors. In 3 contrast, SBA was strictly dependent on the presence of both C2 and high antibody 4 levels. Consequently, it seems that complement-mediated opsonophagocytosis of 5 meningococci can occur even in the presence of low background levels of anti-6 meningococcal antibodies while higher levels of anti-meningococcal antibodies obtained 7 by immunization are needed for detectable SBA to occur (37). The specificity of anti-8 meningococcal antibodies probably also determines whether opsonphagocytosis or 9 bactericidal effects will be effective (1). 10
11
The number of live meningococci in reconstituted C2-deficient whole blood and in blood 12 from the two control donors declined only temporarily before rising again. In accordance 13 with our results from the OPA and SBA experiments, the observed decrease was 14 probably mainly mediated by opsonophagocytosis. Consequently the capacity of killing 15 meningococci by opsonophagocytosis in these experiments was limited. This could be 16 due to low levels of specific antibodies in relation to the rather large inoculum of 10 5 17 bacteria/ml, which presumably is much higher than encountered in the initial phase of 18 meningococcemia. Thus, we speculate whether complement-mediated opsonphagocytosis 19 represents the primary defense mechanism against intruding meningococci in individuals 20 with low SBA; as in non-immunized individuals. This is consistent with previous reports 21 suggesting that opsonophagocytosis may protect against invasive meningococci when 22 sufficient SBA is absent (16, 17) . However, it can not be excluded that the susceptibility 23 on September 13, 2017 by guest http://iai.asm.org/ Downloaded from of the meningococci to SBA was increased in the whole blood experiments compared to 1 the SBA experiments, because the bacteria used in the former were in the stationary 2 phase whereas those in the latter were in log phase. Thus, bactericidal killing may also 3 have contributed to the killing of meningococci in the whole blood experiments. 4 5 Interestingly, the ability to kill meningococci was also absent in C5-deficient whole 6 blood. Obviously no formation of the lytic terminal C5b-9 complement complex took 7 place in the absence of C5. Our results indicate, however, that efficient killing by 8 opsonophagocytosis did not occur in C5-deficient whole blood. Opsonophagocytosis of 9 meningococci is initiated by the binding of C3 split products, mainly iC3b deposited onto 10 the surface of bacteria, to CD11b/CD18 (complement receptor 3, CR3) on the phagocytes 11 to a large extent survived and proliferated, there was a substantial difference of 2-3 log 10 20 in total increase of CFUs and number of DNA copies; which illustrates that most of the 21 bacteria died after proliferation. The mechanism behind this is not known. 22
In sharp contrast to the modest killing of meningococci in the previously discussed blood 1 samples was the efficient killing of all live bacteria observed in reconstituted blood from 2 the C5-deficient patient. The high concentration of anti-meningococcal antibodies she 3 had increased the efficiency of opsonophagocytosis, as was also confirmed by the OPA 4 experiments using heat-inactivated post-vaccination serum as source of antibodies and 5 the reconstituted C5-deficient serum as complement source. Thereby it seemed that even 6 if opsonophagocytosis occurred in the presence of low antibody levels, as in sera from 7 non-immunized individuals, it was increased by immunization. This is in accordance with 8 previous studies performed with serum from immunized individuals (1,34). The efficient 9 killing of meningococci in the reconstituted C5-deficient whole blood was obviously also 10 due to high SBA. 11
12
From clinical studies, MBL is suggested to play a protective role against meningococcal 13 disease in early childhood; before a normal background antibody level is obtained 14 (8, 11, 15, 19, 45) . In the present study proliferation of meningococci in whole blood from 15 the MBL-deficient control was identical to the proliferation seen in reconstituted blood 16 from the C2-deficient patient and the respective MBL-sufficient matched control. As 17 these three donors were comparable with respect to their equally low levels of anti- 
